NCT04666038 2025-04-20BRUIN CLL-321Eli Lilly and CompanyPhase 3 Active not recruiting238 enrolled 17 charts 1 FDA
NCT01100502 2021-05-14A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)Seagen Inc.Phase 3 Completed329 enrolled 15 charts
NCT00773747 2021-04-30Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)Merck Sharp & Dohme LLCPhase 3 Completed637 enrolled 15 charts
NCT01650805 2014-11-17Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)Ariad PharmaceuticalsPhase 3 Terminated307 enrolled 11 charts
NCT00074763 2012-08-02Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous PlateletsM.D. Anderson Cancer CenterPhase 3 Terminated4 enrolled